Cooley advised RAPT Therapeutics, Inc. and Davis Polk & Wardwell advised the sales agents on the offering. RAPT Therapeutics, Inc. (Nasdaq:RAPT) announced the SEC-registered at-the-market offering of its common...
You must be a Standard 1 Year member to access this content.
Cooley LLP advised NGM Biopharmaceuticals, while Davis Polk & Wardwell advised Jefferies, as sales agent in the offering. NGM Biopharmaceuticals (NASDAQ:NGM) announced its common stock for up to...
You must be a Standard 1 Year member to access this content.
Cooley advised RAPT Therapeutics, while Davis Polk advised the joint book-running managers in the offering. RAPT Therapeutics, Inc. executed a $75 million SEC-registered follow-on offering of 4,054,055...
You must be a Standard 1 Year member to access this content.
